Search results
British Societies Develop First 'Living' Behçet Guidelines
Medscape· 3 days agoThe British Society for Rheumatology (BSR) and the British Association of Dermatologists (BAD) have...
Wartburg community rallies for 17-year-old diagnosed with rare autoimmune disorder
WBIR-TV Knoxville· 5 days agoIan Pemberton was hospitalized as of Tuesday evening, and the Wartburg community rallied to support...
What is hiker's rash? And is it serious?
Advnture via Yahoo News· 4 days agoOr forget to put sunscreen on your legs? While you’ll want to rule out both poisonous plants and sunburn, your red, itchy skin may actually just be...
Review explores cutaneous manifestations of myelodysplastic syndrome
Medical Xpress· 7 days agoCutaneous manifestations of myelodysplastic syndrome (MDS) are described in a perspective piece...
Arthritis Medications: NSAIDs, Steroids, Narcotics, Topical Treatments, and More
WebMD· 3 days agoThere are dozens of medications available with or without a prescription to treat the various forms of arthritis. Nonsteroidal anti-inflammatory drugs or NSAIDs are available both over the counter and by prescription.
Kim Kardashian 'Over' Taylor Swift Feud, Thinks Singer Should 'Move On' After Suspected 'thanK you...
RadarOnline.com· 5 days agoKim Kardashian was said to be “over” her bad blood feud with Taylor Swift after the singer released...
Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and...
Morningstar· 6 days agoRecludix Pharma, a leader in platform approaches to discover inhibitors of challenging targets for inflammatory disease and cancer, today announced the appointment of Ajay Nirula, M.D., Ph.D ...
Handelsbanken Fonder AB Has $9.84 Million Position in argenx SE (NASDAQ:ARGX)
ETF DAILY NEWS· 4 days agoHandelsbanken Fonder AB reduced its stake in argenx SE (NASDAQ:ARGX – Free Report) by 5.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned ...
Q2 2024 EPS Estimates for argenx SE (NASDAQ:ARGX) Lifted by Analyst
ETF DAILY NEWS· 5 days agoWilliam Blair analyst M. Minter now expects that the company will post earnings per share of ($0.83) for the quarter, up from their prior forecast of ($1.03). The consensus estimate for argenx’s current full-year earnings is ($2.10) per share.
argenx SE (NASDAQ:ARGX) Shares Sold by EFG Asset Management Americas Corp.
ETF DAILY NEWS· 7 days agoEFG Asset Management Americas Corp. cut its holdings in argenx SE (NASDAQ:ARGX – Free Report) by 23.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The ...
